Understanding how lung and pancreatic cancers spread to other parts of the body
Transition to Metastatic State: Lung Cancer, Pancreatic Cancer and Brain Metastasis
This study is looking at how lung and pancreatic cancers spread to other parts of the body, and it's for patients who want to help researchers understand this process better by providing tissue samples that will be used to create a detailed map of these cancers.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10477032 on NIH RePORTER |
What this research studies
This research investigates the complex processes involved in the spread of lung and pancreatic cancers to other organs, which is a leading cause of cancer-related deaths. By utilizing advanced technologies and computational methods, the team will analyze human tissue samples from patients with these cancers to create a detailed Human Tissue Atlas. This atlas will help researchers understand the transition from localized tumors to metastatic disease, providing insights into the underlying biological mechanisms. Patients' biospecimens will be collected through surgical procedures, biopsies, or autopsies, and subjected to various high-tech analyses to gather comprehensive data.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with lung cancer, pancreatic cancer, or those with brain metastases from these cancers.
Not a fit: Patients with early-stage cancer that has not metastasized or those with cancers other than lung or pancreatic cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with metastatic lung and pancreatic cancers.
How similar studies have performed: Previous research has shown promise in understanding cancer metastasis through similar advanced analytical approaches, indicating potential for success in this novel investigation.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Pe'er, Dana — Sloan-Kettering Inst Can Research
- Study coordinator: Pe'er, Dana
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.